Chubb Limited (NYSE:CB) is one of the most undervalued NYSE stocks to invest in. On May 18, Chubb Limited announced that its subsidiary, Chubb INA Holdings LLC, successfully priced a public offering of $1 billion in 5.30% senior notes. These notes are scheduled to mature in 2036 and are fully guaranteed by the parent company, […]
Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
Underwriting discipline has propelled the property and casualty insurer to No. 1 in industry profitability under Greenberg’s leadership.
In the most recent trading session, Chubb (CB) closed at $323.4, indicating a -1.39% shift from the previous trading day.
Trupanion is showing stronger earnings, record operating margins, and loyal subscribers, but investors question competition and veterinary inflation.
The Progressive Corporation (NYSE:PGR) was among Jim Cramer’s stock calls on Mad Money, as he highlighted worthy space players and reviewed several of this year’s IPOs. When a caller mentioned that it might be the time to start a position in the stock, Cramer said: You know, I gotta tell you, that group is under […]
Although Wall Street has spent the better part of two years cheering an artificial intelligence buildout that has dragged the Nasdaq 100 up roughly 30% over the past year, the technology-packed Nasdaq Composite is starting to wobble at the worst possible moment. The benchmark S&P 500 has slipped, with SPY off about 4% in the ... Today’s AI market hits all 5 warning signs that preceded 2000 Nasdaq crash.
Chubb Limited (NYSE:CB) is included among the 10 Best S&P 500 Dividend Stocks to Buy Right Now. Barclays lowered its price recommendation on Chubb Limited (NYSE:CB) to $368 from $375 on June 12. The firm reiterated an Equal Weight rating on the stock. It said earnings upside in the property and casualty insurance sector is […]
In recent days, Chubb reported strong quarterly results, raised its dividend for the 33rd consecutive year, and approved a multi-billion dollar share repurchase program, signaling continued focus on shareholder returns. This combination of robust operations and larger capital returns offers fresh insight into how Chubb is prioritizing cash distribution while maintaining its insurance franchise. Next, we’ll examine how Chubb’s larger share buyback authorization shapes the existing...
RenaissanceRe (RNR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Insurance firms play a critical role in the financial system, offering everything from property coverage to life insurance and specialized risk solutions. But worries about an economic slowdown and potential claims deterioration have kept sentiment in check, and over the past six months, the industry has tumbled by 3.4%. This performance is a far cry from the S&P 500’s 6.9% ascent.
Zacks.com users have recently been watching Chubb (CB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Chubb (CB) reached $321.88 at the closing of the latest trading day, reflecting a -1.35% change compared to its last close.
Major insurers such as Allstate, Liberty Mutual and Nationwide kept at least 15% of their holdings in assets such as private equity and hedge funds last year, according to research by S&P Global Market Intelligence. Other carriers, including The Hartford Insurance Group, Chubb and USAA, keep less money in such investments, but their share more than doubled in the past decade, S&P Global analyst Tim Zawacki found. Property and casualty insurers’ moves into so-called alternative investments have picked up just as many pensions and endowments have started to question whether the returns those funds can generate will be as attractive as they have been in decades past.
Illiquid assets are a fixture in life-insurer portfolios. But property insurers have sudden payouts for hurricanes or wildfires, making illiquidity a riskier proposition.
Allstate has outperformed its industry peers recently, and analysts remain moderately optimistic about the stock’s prospects.
MetLife, Globe Life, and Unum Group are hitting 52-week highs as P&C premiums decline, rewarding insurers with life, group benefits, and health exposure.
Chubb stock: setting the stage Chubb (CB) has drawn investor attention after recent trading put the stock at $326.27, with returns of 3.7% over the past week and 2.1% over the past month. See our latest analysis for Chubb. The recent 3.7% 1 day share price return and 4.7% 7 day share price return sit alongside a 5.2% year to date share price gain. The 1 year total shareholder return of 12.5% points to momentum that has been building rather than fading. If this kind of steady compounding...
American Financial benefits from a large investment portfolio, with rising yields and invested assets helping drive earnings growth.
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.
Chubb (NYSE:CB) has approved a 5.2% increase in its annual dividend, marking the 33rd consecutive yearly raise. The company also authorized a new $7.5b share repurchase program as part of its capital return approach. These actions highlight ongoing efforts to return capital to shareholders through both dividends and buybacks. For investors watching Chubb at a share price of $312.27, the latest capital return moves come after a mixed run in the stock. Shares are up 6.7% over the past year...
While Chubb has underperformed its industry peers recently, analysts remain moderately optimistic about the stock’s prospects.
Chubb Limited is leveraging acquisitions, premium growth and rising investment income to drive long-term growth.
Chubb Limited (NYSE:CB) is included among the 15 Best Dividend Paying Stocks to Buy Right Now. On May 26, Piper Sandler increased its price recommendation on Chubb Limited (NYSE:CB) to $340 from $328. It reiterated a Neutral rating on the stock. The firm pointed to recent share performance and the passage of time as factors […]
Chubb Limited (NYSE:CB) is one of the 12 Undervalued Financial Stocks to Buy Now. On May 26, 2026, Piper Sandler raised the firm’s price target on Chubb Limited (NYSE:CB) to $340 from $328 and maintained a Neutral rating on the shares. Piper Sandler cited recent stock performance and the roll-forward of time. The firm said […]
AIZ is using AI, automation and digital platforms to improve claims, device lifecycle management and customer experience across its businesses.
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the multi-line insurance stocks, including Chubb (NYSE:CB) and its peers.
Berkshire Hathaway's insurance float fuels investments as the company shifts to Japan trading houses and builds BHE renewables, backed by $370B+ cash.
Chubb (CB) has put shareholder returns in the spotlight after its 2026 Annual General Meeting, with investors approving a 5.2% dividend increase and the Board authorizing a new US$7.5b share repurchase program. See our latest analysis for Chubb. The dividend and buyback news comes as Chubb’s share price has gained 5.8% year to date. The 1 year total shareholder return of 16.1% and 5 year total shareholder return of 108.1% point to momentum that has built over time. If this kind of steady...
Earlier in May 2026, Chubb Limited shareholders approved a 5.2% dividend increase to US$4.08 annually and authorized a US$7.50 billion share repurchase program with no expiration, while a subsidiary issued US$1.00 billion of 5.30% senior notes due 2036 guaranteed by the parent. Alongside these capital actions, Chubb’s Canadian benefits unit launched Combined Cancer Care, a supplemental insurance product aimed at easing the substantial non-medical financial burden faced by cancer patients and...